At the completion of this activity, the participant will be able to:
1. Discuss the pathophysiology of SE/RSE/SRSE and why patients progress to refractory states
2. Describe current practices of continuous infusions utilized for SE/RSE/SRSE
3. Review new-generation oral agents for treatment of SE/RSE/SRSE
4. Identify novel treatment strategies for SE/RSE/SRSE

Session date: 
10/17/2022 - 12:00pm to 1:00pm EDT
Location: 
AGH Lecture Hall (1st Floor South Tower) & Zoom Webinar
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454
Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.